华海药业：2025年前三季度净利润约3.80亿元

Group 1 - The core viewpoint of the article highlights Huahai Pharmaceutical's significant decline in both revenue and net profit for the third quarter of 2023 compared to the same period last year [1] Group 2 - Huahai Pharmaceutical reported a revenue of approximately 6.409 billion yuan for the first three quarters of 2025, representing a year-on-year decrease of 11.57% [1] - The net profit attributable to shareholders of the listed company was about 380 million yuan, reflecting a year-on-year decrease of 63.12% [1] - The basic earnings per share stood at 0.26 yuan, which is a decrease of 63.38% compared to the previous year [1]